Screener
Stock Screener
Stock60 | Sector / Industry | EPS (TTM) |
|---|
Stock60 | Sector / Industry | Market Cap | Revenue (TTM) | EPS (TTM) | P/E | P/S | Gross Margin | Net Margin |
|---|---|---|---|---|---|---|---|---|
Drug Manufacturers - Specialty & Generic | $32.32B-52.2% | $9.51B+2.6% | 6.03+9.6% | 12.2x | 3.4x | 71.8% | 27.8% | |
Drug Manufacturers - Specialty & Generic | $20.53B+95.7% | $14.56B+1.6% | -0.26+91.8% | — | 1.4x | 34.4% | -2.0% | |
Drug Manufacturers - Specialty & Generic | $16.9B+33.1% | $3.1B+28.6% | 6.49+120% | 25.3x | 5.5x | 98.2% | 21.6% | |
Drug Manufacturers - Specialty & Generic | $12.85B+83.8% | $4.89B+10.5% | -0.50-166% | — | 2.6x | 55.1% | -4.9% | |
Drug Manufacturers - Specialty & Generic | $6.59B+33.3% | $1.55B+0.6% | 4.14+12.2% | 23.6x | 4.3x | 60.5% | 18.0% | |
Drug Manufacturers - Specialty & Generic | $6.02B+141% | $3.05B+7.6% | 0.38+1,050% | 49.3x | 2.0x | 38.7% | 4.0% | |
Drug Manufacturers - Specialty & Generic | $4.42B+66.8% | $1.29B+10.3% | 1.95+9,850% | 17.6x | 3.4x | 81.3% | 19.4% | |
Drug Manufacturers - Specialty & Generic | $3.03B-55.5% | — | — | — | — | — | — | |
Drug Manufacturers - Specialty & Generic | $2.67B+28.9% | $776.83M+16.3% | -0.51-146% | — | 3.4x | 89.4% | -3.7% | |
Drug Manufacturers - Specialty & Generic | $2.62B+22.5% | $10.53B+8.2% | -3.10-560% | — | 0.3x | 71.4% | -1.9% | |
Drug Manufacturers - Specialty & Generic | $1.82B+28.5% | $923.71M+37.0% | 3.94+410% | 19.8x | 2.0x | 60.8% | 10.0% | |
Drug Manufacturers - Specialty & Generic | $1.51B+37.0% | $1.5B+26.0% | 2.34+200% | 15.8x | 1.0x | 32.5% | 6.3% | |
Drug Manufacturers - Specialty & Generic | $1.48B-60.1% | $4.18B-3.6% | -13.12-902% | — | 0.3x | 34.2% | -43.5% | |
Drug Manufacturers - Specialty & Generic | $1.28B-53.8% | — | — | — | — | — | — | |
Drug Manufacturers - Specialty & Generic | $1.15B+15.5% | $796.33M+19.9% | 2.04+67.2% | 15.4x | 1.4x | 60.7% | 9.4% | |
Drug Manufacturers - Specialty & Generic | $1.06B-0.3% | $734.86M+4.6% | 0.12+105% | 206.2x | 1.4x | 79.3% | 0.7% | |
Drug Manufacturers - Specialty & Generic | $1.06B+35.8% | $159.54M+28.1% | — | — | 6.6x | 42.7% | -1.1% | |
Drug Manufacturers - Specialty & Generic | $891.56M-11.6% | $720.53M-1.4% | 1.66-39.9% | 11.3x | 1.2x | 47.3% | 11.0% | |
Drug Manufacturers - Specialty & Generic | $727.59M+499% | $361.51M+13.8% | 0.60+386% | 7.1x | 2.0x | 99.2% | 28.3% | |
Drug Manufacturers - Specialty & Generic | $631.98M-5.3% | $915.45M+11.5% | — | — | 0.7x | 30.9% | -12.0% | |
Drug Manufacturers - Specialty & Generic | $475.52M+19.1% | $50.27M-7.3% | -0.62-5.1% | — | 9.5x | 63.5% | -137.1% | |
Drug Manufacturers - Specialty & Generic | $417.13M+0.9% | — | — | — | — | — | — | |
Drug Manufacturers - Specialty & Generic | $404.3M+96.7% | $284.6M+5.8% | -1.31+84.0% | — | 1.4x | 24.5% | -92.4% | |
Drug Manufacturers - Specialty & Generic | $398.42M-32.2% | $301.79M+9.6% | -0.67+23.9% | — | 1.3x | 66.1% | -14.4% | |
Drug Manufacturers - Specialty & Generic | $382.33M+18.4% | $676.8M-29.9% | 1.95+152% | 3.4x | 0.6x | 54.2% | 9.6% |
